封面
市场调查报告书
商品编码
1266692

干细胞化验的全球市场:趋势,机会,竞争分析(2023年~2028年)

Stem Cell Assay Market: Trends, Opportunities and Competitive Analysis [2023-2028]

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球干细胞化验的市场规模,预计从2023年至2028年以19.1%的年复合成长率成长,到2028年达到估计40亿美元。促进市场成长的主要原因,是干细胞的治疗能力的认识高涨,目前干细胞培养技术的接受率上升,癌症和心血管疾病的病例增加等。

本报告提供全球干细胞化验市场调查,市场概要,市场规模和预测,趋势,促进因素、课题,各化验类型、各细胞类型、各产品、各服务、各用途、各最终用途产业、各地区等的分析,再加上竞争分析等资讯。

目录

第1章 摘要整理

第2章 全球干细胞化验市场:市场动态

  • 简介,背景,及分类
  • 供应链
  • 产业的推动因素与课题

第3章 市场趋势与预测分析(2017年~2028年)

  • 宏观经济趋势(2017年~2022年)与预测(2023年~2028年)
  • 全球干细胞化验市场趋势(2017年~2022年)与预测(2023年~2028年)
  • 全球干细胞化验市场:各化验类型
    • 生存能力/细胞毒性
    • 分离、精製
    • 细胞鑑定
    • 增生
    • 分化
    • 功能
    • 细胞凋亡
    • 其他
  • 全球干细胞化验市场:各细胞类型
    • 成体干细胞
    • 间质干细胞
    • 诱导性多功能干细胞
    • 造血干细胞
    • 脐带干细胞
    • 神经干细胞
    • 人类胚胎干细胞
  • 全球干细胞化验市场:各产品、服务
    • 设备
    • 流式细胞仪
    • 微电极阵列
    • 细胞成像、分析系统
    • 自动细胞计数器
    • 套件
    • 服务
  • 全球干细胞化验市场:各用途
    • 再生医疗、治疗开发
    • 整形外科,肌肉骨骼,脊椎
    • 皮肤科
    • 心血管
    • 中枢神经系统
    • 肿瘤学
    • 糖尿病
    • 药物研发、开发
  • 全球干细胞化验市场:各最终用途产业
    • 生物医药品、生物科技企业
    • 学术、研究机关

第4章 市场趋势与预测分析:各地区(2017年~2028年)

  • 各地区的干细胞化验市场
  • 北美的干细胞化验市场
    • 北美的干细胞化验市场,各化验类型:生存能力/细胞毒性,分离、精製,细胞鑑定,增生,分化,功能,细胞凋亡,其他
    • 北美的干细胞化验市场,各最终用途产业:生物医药品、生物科技企业,学术、研究机关
  • 欧洲的干细胞化验市场
    • 欧洲的干细胞化验市场,各化验类型:生存能力/细胞毒性,分离、精製,细胞鑑定,增生,分化,功能,细胞凋亡,其他
    • 欧洲的干细胞化验市场,各最终用途产业:生物医药品、生物科技企业,学术、研究机关
  • 亚太地区的干细胞化验市场
    • 亚太地区的干细胞化验市场,各化验类型:生存能力/细胞毒性,分离、精製,细胞鑑定,增生,分化,功能,细胞凋亡,其他
    • 亚太地区的干细胞化验市场,各最终用途产业:生物医药品、生物科技企业,学术、研究机关
  • 其他地区的干细胞化验市场
    • 其他地区的干细胞化验市场,各化验类型:生存能力/细胞毒性,分离、精製,细胞鑑定,增生,分化,功能,细胞凋亡,其他
    • 其他地区的干细胞化验市场,各最终用途产业:生物医药品、生物科技企业,学术、研究机关

第5章 竞争分析

  • 产品系列分析
  • 运用整合
  • 波特的五力分析

第6章 成长机会及策略分析

  • 成长机会分析
    • 全球干细胞化验市场成长机会:各化验类型
    • 全球干细胞化验市场成长机会:各细胞类型
    • 全球干细胞化验市场成长机会:各产品、服务
    • 全球干细胞化验市场成长机会:各用途
    • 全球干细胞化验市场成长机会:各最终用途产业
    • 全球干细胞化验市场成长机会:各地区
  • 全球干细胞化验市场上新的趋势
  • 策略分析
    • 新产品的开发
    • 全球干细胞化验市场通讯容量扩大
    • 全球干细胞化验市场的合併,收购,合资企业
    • 检定和授权

第7章 主要企业的企业简介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories
简介目录

Stem Cell Assay Market Trends and Forecast

The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Stem Cell Assay Market by Segment

The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:

Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Viability or Cytotoxicity
  • Isolation and Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis
  • Others

Stem Cell Assay Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Adult
  • Mesenchymal
  • Induced Pluripotent
  • Hematopoietic
  • Umbilical Cord
  • Neural
  • Human Embryonic

Stem Cell Assay Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging & Analysis Systems
  • Automated Cell Counters
  • Kits
  • Services

Stem Cell Assay Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Regenerative Medicine & Therapy Development
  • Orthopedic, Musculoskeletal, and Spine Application
  • Dermatology Application
  • Cardiovascular Application
  • CNS Application
  • Oncology Application
  • Diabetes Application
  • Drug Discovery & Development
  • Clinical Research

Stem Cell Assay Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

Stem Cell Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stem Cell Assay Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Stem Cell Assay Market Insights

  • Lucintel forecasts that viability/cytotoxicity assay will remain the largest type segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
  • Within this market, the biopharmaceutical & biotechnology companies segment is expected to record the highest growth due to growing prevalence of chronic diseases, an increase in the number of clinical trials, and growing strategic activities along with improvements in healthcare services.
  • North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Features of the Stem Cell Assay Market

  • Market Size Estimates: Stem cell assay market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Stem cell assay market size by various segments, such as by type, cell type, product & service, application, end use industry, and region
  • Regional Analysis: Stem cell assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by type, cell type, product & service, application, end use industry, and regions for the stem cell assay market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell assay market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the stem cell assay market size?

Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.

Q2. What is the growth forecast for stem cell assay market?

Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the stem cell assay market?

Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

Q4. What are the major segments for stem cell assay market?

Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.

Q5. Who are the key stem cell assay companies?

Answer: Some of the key stem cell assay companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Q6. Which stem cell assay segment will be the largest in future?

Answer:Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.

Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1.What are some of the most promising, high-growth opportunities for the stem cell assay market by type (viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, apoptosis, and others), cell type (adult, mesenchymal, induced pluripotent, hematopoietic, umbilical cord, neural, human embryonic), product & service (instruments, flow cytometers, microelectrode arrays, cell imaging & analysis systems, automated cell counters, and kits services), application (regenerative medicine & therapy development, orthopedic, musculoskeletal, and spine application, dermatology application, cardiovascular application, CNS application, oncology application, diabetes application, drug discovery & development, and clinical research), end use industry (biopharmaceutical & biotechnology companies and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stem Cell Assay Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Stem Cell Assay Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Stem Cell Assay Market by Assay Type
    • 3.3.1: Viability or Cytotoxicity
    • 3.3.2: Isolation and Purification
    • 3.3.3: Cell Identification
    • 3.3.4: Proliferation
    • 3.3.5: Differentiation
    • 3.3.6: Function
    • 3.3.7: Apoptosis
    • 3.3.8: Others
  • 3.4: Global Stem Cell Assay Market by Cell Type
    • 3.4.1: Adult
    • 3.4.2: Mesenchymal
    • 3.4.3: Induced Pluripotent
    • 3.4.4: Hematopoietic
    • 3.4.5: Umbilical Cord
    • 3.4.6: Neural
    • 3.4.7: Human Embryonic
  • 3.5: Global Stem Cell Assay Market by Product & Service
    • 3.5.1: Instruments
    • 3.5.2: Flow Cytometers
    • 3.5.3: Microelectrode Arrays
    • 3.5.4: Cell Imaging & Analysis Systems
    • 3.5.5: Automated Cell Counters
    • 3.5.6: Kits
    • 3.5.7: Services
  • 3.6: Global Stem Cell Assay Market by Application
    • 3.6.1: Regenerative Medicine & Therapy Development
    • 3.6.2: Orthopedic, Musculoskeletal, and Spine Application
    • 3.6.3: Dermatology Application
    • 3.6.4: Cardiovascular Application
    • 3.6.5: CNS Application
    • 3.6.6: Oncology Application
    • 3.6.7: Diabetes Application
    • 3.6.8: Drug Discovery & Development
  • 3.7: Global Stem Cell Assay Market by End Use Industry
    • 3.7.1: Biopharmaceutical & Biotechnology Companies
    • 3.7.2: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Stem Cell Assay Market by Region
  • 4.2: North American Stem Cell Assay Market
    • 4.2.1: North American Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.2.2: North American Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.3: European Stem Cell Assay Market
    • 4.3.1: European Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.3.2: European Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.4: APAC Stem Cell Assay Market
    • 4.4.1: APAC Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.4.2: APAC Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.5: ROW Stem Cell Assay Market
    • 4.5.1: ROW Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.5.2: ROW Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stem Cell Assay Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global Stem Cell Assay Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Stem Cell Assay Market by Product & Service
    • 6.1.4: Growth Opportunities for the Global Stem Cell Assay Market by Application
    • 6.1.5: Growth Opportunities for the Global Stem Cell Assay Market by End Use Industry
    • 6.1.6: Growth Opportunities for the Global Stem Cell Assay Market by Region
  • 6.2: Emerging Trends in the Global Stem Cell Assay Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stem Cell Assay Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Assay Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Danaher
  • 7.4: Becton, Dickinson and Company
  • 7.5: Agilent Technologies
  • 7.6: Bio-Techne Corporation
  • 7.7: Lonza Group
  • 7.8: PerkinElmer
  • 7.9: Cell Biolabs
  • 7.10: Bio-Rad Laboratories